Nevro Corp (Nevro) is a medical device company, which is engaged in developing novel products that advance the quality of life for people suffering from chronic pain in trunks and limbs. The company has developed Nevro Senza spinal cord stimulation (SCS) system, a non-pharmacological neuromodulation platform for the treatment of chronic pain. The Nevro Senza SCS system is commercially available in the US, Europe, and Australia. The company offers products under Senza, Senza II, Senza Omnia and the Nevro logo brands. Nevro is developing HF10 therapy for treatment related to painful diabetic neuropathy and non-surgical refractory back pain. Nevro is headquartered in Redwood City, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Nevro Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Nevro Corp Company Overview
- Nevro Corp Company Snapshot
- Nevro Corp Pipeline Products and Ongoing Clinical Trials Overview
- Nevro Corp - Pipeline Analysis Overview
- Business Description
- Nevro Corp - Key Facts
- Nevro Corp - Major Products and Services
- Nevro Corp Pipeline Products by Development Stage
- Nevro Corp Ongoing Clinical Trials by Trial Status
- Nevro Corp Pipeline Products Overview
- Omnia Upgrade
- Omnia Upgrade Product Overview
- Senza HF10 Therapy System - Back Pain
- Senza HF10 Therapy System - Back Pain Product Overview
- Senza HF10 Therapy System - Back Pain Clinical Trial
- Senza HF10 Therapy System - Chronic Abdominal Pain
- Senza HF10 Therapy System - Chronic Abdominal Pain Product Overview
- Senza HF10 Therapy System - Chronic Migraine
- Senza HF10 Therapy System - Chronic Migraine Product Overview
- Senza HF10 Therapy System - Chronic Neck Pain
- Senza HF10 Therapy System - Chronic Neck Pain Product Overview
- Senza HF10 Therapy System - CPSP
- Senza HF10 Therapy System - CPSP Product Overview
- Senza HF10 Therapy System - Leg Pain
- Senza HF10 Therapy System - Leg Pain Product Overview
- Senza HF10 Therapy System - Opioid Reduction
- Senza HF10 Therapy System - Opioid Reduction Product Overview
- Senza HF10 Therapy System - Painful Diabetic Neuropathy
- Senza HF10 Therapy System - Painful Diabetic Neuropathy Product Overview
- Senza HF10 Therapy System - Painful Diabetic Neuropathy Clinical Trial
- Senza HF10 Therapy System - Pelvic Pain
- Senza HF10 Therapy System - Pelvic Pain Product Overview
- Senza HF10 Therapy System - Pelvic Pain Clinical Trial
- Senza HF10 Therapy System - Peripheral Polyneuropathy
- Senza HF10 Therapy System - Peripheral Polyneuropathy Product Overview
- Senza HF10 Therapy System - Post-Surgical Pain
- Senza HF10 Therapy System - Post-Surgical Pain Product Overview
- Senza HF10 Therapy System - Rescue Therapy
- Senza HF10 Therapy System - Rescue Therapy Product Overview
- Senza HF10 Therapy System - Thoracic Pain
- Senza HF10 Therapy System - Thoracic Pain Product Overview
- Senza HF10 Therapy System - Upper Extremity Pain
- Senza HF10 Therapy System - Upper Extremity Pain Product Overview
- Senza HF10 Therapy System - Upper Limb Pain
- Senza HF10 Therapy System - Upper Limb Pain Product Overview
- Senza HFX iQ Spinal Cord Stimulation System
- Senza HFX iQ Spinal Cord Stimulation System Product Overview
- Nevro Corp - Key Competitors
- Nevro Corp - Key Employees
- Nevro Corp - Key Employee Biographies
- Nevro Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Nevro Corp, Recent Developments
- Apr 19, 2023: Nevro names Kevin Thornal as new chief executive officer and president
- Oct 10, 2022: Nevro Comments on UnitedHealthcare Medical Coverage Policy Update
- Sep 01, 2022: Nevro announces multiple positive coverage updates for the treatment of painful diabetic neuropathy
- Apr 06, 2022: Nevro to Report First Quarter 2022 Financial Results
- Mar 07, 2022: Nevro announces positive Medicare coverage update from Noridian for the treatment of painful diabetic neuropathy
- Oct 11, 2021: Nevro to Report Third Quarter 2021 Financial Results
- Aug 26, 2021: Nevro to Present at Baird 2021 Global Healthcare Conference
- May 05, 2021: Nevro Reports First Quarter 2021 Financial Results and Updates 2021
- Feb 01, 2021: Nevro to Present at Citi''s 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference
- Feb 01, 2021: Nevro to Present at 10th Annual SVB Leerink Global Healthcare Conference
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Nevro Corp Pipeline Products and Ongoing Clinical Trials Overview
- Nevro Corp Pipeline Products by Equipment Type
- Nevro Corp Pipeline Products by Indication
- Nevro Corp Ongoing Clinical Trials by Trial Status
- Nevro Corp, Key Facts
- Nevro Corp, Major Products and Services
- Nevro Corp Number of Pipeline Products by Development Stage
- Nevro Corp Pipeline Products Summary by Development Stage
- Nevro Corp Ongoing Clinical Trials by Trial Status
- Nevro Corp Ongoing Clinical Trials Summary
- Omnia Upgrade - Product Status
- Omnia Upgrade - Product Description
- Senza HF10 Therapy System - Back Pain - Product Status
- Senza HF10 Therapy System - Back Pain - Product Description
- Senza HF10 Therapy System - Back Pain - A Multi-center, Prospective, Pragmatic, Randomized, Controlled Clinical Trial to Compare HF10 Therapy to Conventional Medical Management in the Treatment of Non-surgical Refractory Back Pain
- Senza HF10 Therapy System - Chronic Abdominal Pain - Product Status
- Senza HF10 Therapy System - Chronic Abdominal Pain - Product Description
- Senza HF10 Therapy System - Chronic Migraine - Product Status
- Senza HF10 Therapy System - Chronic Migraine - Product Description
- Senza HF10 Therapy System - Chronic Neck Pain - Product Status
- Senza HF10 Therapy System - Chronic Neck Pain - Product Description
- Senza HF10 Therapy System - CPSP - Product Status
- Senza HF10 Therapy System - CPSP - Product Description
- Senza HF10 Therapy System - Leg Pain - Product Status
- Senza HF10 Therapy System - Leg Pain - Product Description
- Senza HF10 Therapy System - Opioid Reduction - Product Status
- Senza HF10 Therapy System - Opioid Reduction - Product Description
- Senza HF10 Therapy System - Painful Diabetic Neuropathy - Product Status
- Senza HF10 Therapy System - Painful Diabetic Neuropathy - Product Description
- Senza HF10 Therapy System - Painful Diabetic Neuropathy - A Post-market, Multicenter, Prospective, Global Clinical Study to Evaluate the Real-world Experience of Spinal Cord Stimulation That Includes 10 kHz in the Management of Chronic Intractable Pain Associated with Diabetic Neuropathy
- Senza HF10 Therapy System - Painful Diabetic Neuropathy - A Post-market, Multicenter, Prospective, Randomized Clinical Trial Comparing 10 kHz Spinal Cord Stimulation (HF10 Therapy) Combined with Conventional Medical Management to Conventional Medical Management Alone in the Treatment of Chronic, Intractable, Neuropathic Limb Pain
- Senza HF10 Therapy System - Painful Diabetic Neuropathy - PDN-SENSORY: A Multi-Center Randomized Controlled Trial to Evaluate Pain and Neurological Function with 10 kHz SCS in Treatment of Painful Diabetic Neuropathy
- Senza HF10 Therapy System - Pelvic Pain - Product Status
- Senza HF10 Therapy System - Pelvic Pain - Product Description
- Senza HF10 Therapy System - Pelvic Pain - A Prospective Clinical Study to Assess the Spinal Cord Stimulation System in the Treatment of Chronic Pelvic Pain
- Senza HF10 Therapy System - Peripheral Polyneuropathy - Product Status
- Senza HF10 Therapy System - Peripheral Polyneuropathy - Product Description
- Senza HF10 Therapy System - Post-Surgical Pain - Product Status
- Senza HF10 Therapy System - Post-Surgical Pain - Product Description
- Senza HF10 Therapy System - Rescue Therapy - Product Status
- Senza HF10 Therapy System - Rescue Therapy - Product Description
- Senza HF10 Therapy System - Thoracic Pain - Product Status
- Senza HF10 Therapy System - Thoracic Pain - Product Description
- Senza HF10 Therapy System - Upper Extremity Pain - Product Status
- Senza HF10 Therapy System - Upper Extremity Pain - Product Description
- Senza HF10 Therapy System - Upper Limb Pain - Product Status
- Senza HF10 Therapy System - Upper Limb Pain - Product Description
- Senza HFX iQ Spinal Cord Stimulation System - Product Status
- Senza HFX iQ Spinal Cord Stimulation System - Product Description
- Nevro Corp, Key Employees
- Nevro Corp, Key Employee Biographies
- Nevro Corp, Subsidiaries
- Glossary
- Nevro Corp Pipeline Products by Equipment Type
- Nevro Corp Pipeline Products by Development Stage
- Nevro Corp Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Stimwave Technologies Inc
- Medtronic Plc
- NeuSpera Medical Inc
- Boston Scientific Corp
- Saluda Medical Pty Ltd
